中文
Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
September 28, 2021
READ ARTICLECategory: Articles
An Approval for Apellis
June 8, 2021
READ ARTICLE
Streamlining the Path to Peptide Market Supply
March 17, 2021
READ ARTICLE New Peptide Toxin-Derived KV1.3 Channel Inhibitor Publication in the British Journal of Pharmacology
March 2, 2021
READ ARTICLE
New Cyclic Peptides Review
February 9, 2021
READ ARTICLE